NCT00481572View on ClinicalTrials.gov

Continuous Infusion of Terlipressin in Septic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Septic Shock
Interventions
DRUG

Terlipressin

continuous terlipressin infusion 1.3 µg•kg-1 over a period of 48 hrs

DRUG

Vasopressin

continuous intravenous infusion of vasopressin 0.03 U•min-1 over a period of 48 hrs

DRUG

Norepinephrine

titrated norepinephrine over a period of 48 hrs

Trial Locations (1)

00161

"Department of Anesthesiology and Intensive care of the University of Rome La Sapienza", Rome, Viale Del Policlinico 155

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT00481572 - Continuous Infusion of Terlipressin in Septic Shock | Biotech Hunter | Biotech Hunter